Join to View Full Profile
Boston University School of Medicine72 East Concord St.Boston, MA 02118
Dr. Wolozin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Albert Einstein College of MedicineClass of 1988
Publications & Presentations
PubMed
- 16 citationsTelomere length change in a multidomain lifestyle intervention to prevent cognitive decline: a randomized clinical trialShireen Sindi, Alina Solomon, Ingemar Kåreholt, Iiris Hovatta, Riitta Antikainen
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2021-02-25 - 13 citationsProtein Interaction Network Biology in Neuroscience.Avik Basu, Peter E.A. Ash, Benjamin Wolozin, Andrew Emili
Proteomics. 2021-02-01 - 17 citationsErratum: Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2 (Molecular Cell (2020) 80(6) (1104–1122.e9), (S1097276520308285), (10.10...Ryan M. Hekman, Adam J. Hume, Raghuveera Kumar Goel, Kristine M. Abo, Jessie Huang
Molecular Cell. 2021-01-07
Journal Articles
- TIA1 Regulates the Generation and Response to Toxic Tau OligomersBenjamin Wolozin, MD, Acta Neuropathologica
- RNA Binding Proteins Co-Localize with Small Tau Inclusions in TauopathyBenjamin Wolozin, MD, BioMed Central
Press Mentions
- Students, Faculty, Administrators Cheer Historic Name Change, Major DonationSeptember 30th, 2022
- Methylated RNA: A New Player in Tau Toxicity?September 14th, 2021
- Alzheimer’s Tau Protein Interacts with RNA to Induce NeurodegenerationAugust 30th, 2021
- Join now to see all
Grant Support
- APOE Genotype Mediated Effects on Alzheimer Disease Risk and MechanismsBOSTON UNIVERSITY MEDICAL CAMPUS2024–2029
- APOE Genotype Mediated Effects on Alzheimer Disease Risk and MechanismsBOSTON UNIVERSITY MEDICAL CAMPUS2024–2029
- The role of N6-methyladenosine modified RNA in Alzheimer's diseaseBOSTON UNIVERSITY MEDICAL CAMPUS2022–2027
- The role of N6-methyladenosine modified RNA in Alzheimer's diseaseBOSTON UNIVERSITY MEDICAL CAMPUS2022–2027
- Development of a novel Alzheimer's disease therapeutic targeting tauAQUINNAH PHARMACEUTICALS, INC.2018–2027
- Development of a novel Alzheimer's disease therapeutic targeting tauAQUINNAH PHARMACEUTICALS, INC.2018–2027
- Development of a novel Alzheimer's disease therapeutic targeting tauAQUINNAH PHARMACEUTICALS, INC.2018–2027
- Development of a novel Alzheimer's disease therapeutic targeting tauAQUINNAH PHARMACEUTICALS, INC.2018–2027
- Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathologyBOSTON UNIVERSITY MEDICAL CAMPUS2021–2026
- Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathologyBOSTON UNIVERSITY MEDICAL CAMPUS2021–2026
- Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathologyBOSTON UNIVERSITY MEDICAL CAMPUS2021–2026
- Circular RNAs and their interactions with RNA-binding proteins to modulate AD-related neuropathologyBOSTON UNIVERSITY MEDICAL CAMPUS2021–2026
- Genetic Modifiers of Protein Interaction Networks in TauopathyBOSTON UNIVERSITY MEDICAL CAMPUS2019–2025
- Stress Granules And The Biology Of TDP-43National Institute Of Environmental Health Sciences2012
- LRRK2 And NeurodegenerationNational Institute Of Neurological Disorders And Stroke2009–2012
- Identification Of Compounds That Inhibit Aggregation And Toxicity Of TDP-43National Institute Of Neurological Disorders And Stroke2011
- The Role Of Stress Granules In The Pathophysiology Of TDP-43National Institute Of Neurological Disorders And Stroke2010–2011
- Interaction Between Genes And The Mitochondria In ParkinNational Institute Of Environmental Health Sciences2006–2010
- Regulation Of APP Processing By PresenilinsNational Institute On Aging2004
- Ubiquitination/Receptor Signaling--Regulation By ParkinNational Institute Of Neurological Disorders And Stroke2004
- Regulation Of APP Processing By PresenilinsNational Institute On Aging2001–2003
- Ubiquitination/Receptor Signaling--Regulation By ParkinNational Institute Of Neurological Disorders And Stroke2001–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: